Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalia Shiryaev

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Journal of Neuroscience Research|June 15, 2010
3R tau expression modifies behavior in transgenic miceNatalia Shiryaev, Yan Jouroukhin, Illana Gozes
Current Pharmaceutical Design|July 7, 2011
Protection against tauopathy by the drug candidates NAP (davunetide) and D-SAL: biochemical, cellular and behavioral aspectsNatalia Shiryaev, Regina Pikman, Eliezer Giladi, et al.
Neurobiology of Disease|March 7, 2009
NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy modelNatalia Shiryaev, Yan Jouroukhin, Eliezer Giladi, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Journal of Neuroscience Research|June 15, 2010
3R tau expression modifies behavior in transgenic miceNatalia Shiryaev, Yan Jouroukhin, Illana Gozes
Current Pharmaceutical Design|July 7, 2011
Protection against tauopathy by the drug candidates NAP (davunetide) and D-SAL: biochemical, cellular and behavioral aspectsNatalia Shiryaev, Regina Pikman, Eliezer Giladi, et al.
Neurobiology of Disease|March 7, 2009
NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy modelNatalia Shiryaev, Yan Jouroukhin, Eliezer Giladi, et al.
Pageof 1